Picture1 20purple 202
Xeno 20square

Xeno Biosciences

Delivering the equivalent of bypass surgery in a safe and effective pill to serve a $300B US market for obesity and related diseases

  • Stage Product In Development
  • Industry Biotechnology
  • Location Somerville, MA, USA
  • Currency USD
  • Founded April 2015
  • Employees 2
  • Incorporation Type C-corp
  • Website xenobiosciences.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.